Related Experiment Video
Updated: May 21, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells
Zhen Liu1, Di Wang, Yongliang Hu
1The 309th Hospital of PLA, No. 17, Heishanhu Street, Beijing, 100091, China.
Background:
Helicobacter pylori is a major human pathogenic bacterium in the gastric mucosa, but to date the regulatory mechanism of the H. pylori-induced inflammatory response is not clear. MicroRNAs have recently emerged as key post-transcriptional regulators of gene expression. We have previously reported that miR-146a negatively regulates the H. pylori-induced inflammatory response, but its molecular mechanism is just beginning to be explored. Our aim was to further explore the key targets of miR-146a and its role of regulation in H. pylori infection.
Methods:
The potential targets of miR-146a were screened through bioinformatic approaches and identified by luciferase reporter assays and green fluorescent protein (GFP) repression experiments. Overexpression and inhibition of miR-146a were used to examine the impacts of miR-146a on its target gene, determined by quantitative real-time polymerase chain reaction (PCR) and western blotting.
Results:
Prostaglandin endoperoxide synthase 2 (PTGS2) is a target gene of miR-146a, and miR-146a decreased PTGS2 expression by degradation of its mRNA, suggesting that the miR-146a-mediated inhibition is a post-transcriptional event. Furthermore, miR-146a and PTGS2 were significantly increased in H. pylori -infected human gastric epithelial cells. Overexpression of miR-146a resulted in significantly reduced PTGS2 production induced by H. pylori infection.
Conclusions:
These results suggest that miR-146a may be involved in negatively regulating H. pylori-induced PTGS2 expression in human gastric epithelial cells.
Insights
MicroRNA-146a (miR-146a) targets and downregulates prostaglandin endoperoxide synthase 2 (PTGS2) expression. This finding clarifies a key regulatory mechanism in Helicobacter pylori infection and gastric inflammation.
Area of Science:
- Molecular Biology
- Microbiology
- Immunology
Background:
- Helicobacter pylori infection triggers inflammation in the gastric mucosa.
- The precise regulatory mechanisms of H. pylori-induced inflammation remain unclear.
- MicroRNAs (miRNAs) are emerging as critical post-transcriptional regulators.
Purpose of the Study:
- To identify key targets of miR-146a.
- To elucidate the regulatory role of miR-146a in H. pylori infection.
Main Methods:
- Bioinformatic screening, luciferase reporter assays, and GFP repression identified miR-146a targets.
- Quantitative real-time PCR and western blotting assessed gene and protein expression.
- Overexpression and inhibition studies modulated miR-146a levels.
Main Results:
- Prostaglandin endoperoxide synthase 2 (PTGS2) was identified as a direct target of miR-146a.
- miR-146a reduces PTGS2 expression via mRNA degradation, indicating post-transcriptional regulation.
- Both miR-146a and PTGS2 levels were elevated in H. pylori-infected gastric cells.
- Overexpressing miR-146a significantly reduced H. pylori-induced PTGS2 production.
Conclusions:
- miR-146a negatively regulates H. pylori-induced PTGS2 expression in human gastric epithelial cells.
- This study reveals a novel molecular mechanism involving miR-146a in H. pylori pathogenesis.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
Related Concept Videos
Gastritis II: Pathophysiology
MicroRNAs
MicroRNAs
Peptic Ulcer Disease II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...